SIMILAR PATTERNS OF AMINO ACIDS FOR 5M66_C_ADNC502_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1aua | PHOSPHATIDYLINOSITOLTRANSFER PROTEINSEC14P (Saccharomycescerevisiae) |
PF00650(CRAL_TRIO)PF03765(CRAL_TRIO_N) | 5 | THR A 25ASP A 20LYS A 116ASP A 117LEU A 22 | None | 1.29A | 5m66C-1auaA:undetectable | 5m66C-1auaA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gq7 | PROCLAVAMINATEAMIDINO HYDROLASE (Streptomycesclavuligerus) |
PF00491(Arginase) | 5 | HIS A 146ASP A 237THR A 247GLY A 161HIS A 160 | MN A 351 (-3.3A) MN A 351 (-2.2A)NoneNoneNone | 1.40A | 5m66C-1gq7A:2.5 | 5m66C-1gq7A:21.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kq3 | GLYCEROLDEHYDROGENASE (Thermotogamaritima) |
PF00465(Fe-ADH) | 5 | HIS A 252ASP A 169THR A 118LEU A 248GLY A 247 | ZN A 401 (-3.2A) ZN A 401 (-2.4A)TRS A2922 ( 4.2A)NoneNone | 1.27A | 5m66C-1kq3A:2.5 | 5m66C-1kq3A:22.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1oal | SUPEROXIDE DISMUTASE (Photobacteriumleiognathi) |
PF00080(Sod_Cu) | 5 | HIS A 88GLN A 48ASP A 91GLY A 69HIS A 47 | ZN A 152 (-3.0A)None ZN A 152 (-2.2A)None CU A 153 (-3.1A) | 1.36A | 5m66C-1oalA:undetectable | 5m66C-1oalA:15.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p8r | ARGINASE 1 (Rattusnorvegicus) |
PF00491(Arginase) | 5 | HIS A 126ASP A 234THR A 244GLY A 142HIS A 141 | MN A 500 ( 3.2A) MN A 500 ( 2.1A)NoneS2C A 551 ( 3.9A)S2C A 551 (-3.7A) | 1.47A | 5m66C-1p8rA:undetectable | 5m66C-1p8rA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) |
PF00465(Fe-ADH) | 5 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.35A | 5m66C-1rrmA:4.2 | 5m66C-1rrmA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uzg | MAJOR ENVELOPEPROTEIN E (Dengue virus) |
PF00869(Flavi_glycoprot)PF02832(Flavi_glycop_C) | 5 | THR A 313THR A 40ASP A 42LEU A 319PHE A 11 | None | 1.44A | 5m66C-1uzgA:undetectable | 5m66C-1uzgA:22.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 54THR A 56ASP A 134THR A 201LYS A 230ASP A 234LEU A 392GLY A 397HIS A 398MET A 403PHE A 407 | ADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)NAD A 501 ( 2.8A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.31A | 5m66C-1v8bA:59.7 | 5m66C-1v8bA:53.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1woi | AGMATINASE (Deinococcusradiodurans) |
PF00491(Arginase) | 5 | THR A 178GLN A 141ASP A 231LEU A 181HIS A 145 | NoneNone MN A1502 (-2.0A)None MN A1502 (-3.4A) | 1.35A | 5m66C-1woiA:undetectable | 5m66C-1woiA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b24 | NAPHTHALENEDIOXYGENASE LARGESUBUNIT (Rhodococcus sp.NCIMB 12038) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A) | 5 | THR A 322THR A 217ASP A 372GLY A 363PHE A 210 | NoneIND A 503 ( 4.3A) FE A 502 (-2.1A)NoneIND A 503 ( 4.4A) | 1.29A | 5m66C-2b24A:undetectable | 5m66C-2b24A:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bq8 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Homo sapiens) |
PF00149(Metallophos) | 5 | THR X 136ASP X 91ASP X 12LEU X 86GLY X 183 | NoneNoneFE2 X1305 (-3.1A)NoneNone | 1.18A | 5m66C-2bq8X:undetectable | 5m66C-2bq8X:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ftz | GERANYLTRANSTRANSFERASE (Thermotogamaritima) |
PF00348(polyprenyl_synt) | 5 | ASP A 48THR A 44GLY A 249MET A 186PHE A 176 | NoneNoneMLY A 248 ( 2.4A)NoneMLY A 181 ( 4.5A) | 1.05A | 5m66C-2ftzA:undetectable | 5m66C-2ftzA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pts | ADENYLOSUCCINATELYASE (Escherichiacoli) |
PF00206(Lyase_1)PF08328(ASL_C) | 5 | THR A 246ASP A 336THR A 338LYS A 327HIS A 251 | None | 1.48A | 5m66C-2ptsA:undetectable | 5m66C-2ptsA:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qjo | BIFUNCTIONAL NMNADENYLYLTRANSFERASE/NUDIX HYDROLASE (Synechocystissp. PCC 6803) |
PF00293(NUDIX)PF01467(CTP_transf_like) | 5 | HIS A 328GLN A 330ASP A 205THR A 203PHE A 272 | APR A 501 (-4.0A)NoneAPR A 501 (-2.8A)APR A 501 (-3.6A)None | 1.35A | 5m66C-2qjoA:2.2 | 5m66C-2qjoA:21.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qjt | NICOTINAMIDE-NUCLEOTIDEADENYLYLTRANSFERASE (Francisellatularensis) |
no annotation | 5 | HIS B 332GLN B 334ASP B 207THR B 205PHE B 274 | None | 1.49A | 5m66C-2qjtB:undetectable | 5m66C-2qjtB:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rjt | BETA-KETOACYL-ACPSYNTHASE II (Streptococcuspneumoniae) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | THR A 335THR A 393LEU A 338GLY A 232HIS A 337 | None | 1.44A | 5m66C-2rjtA:undetectable | 5m66C-2rjtA:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | HIS A 316THR A 315GLY A 306HIS A 310MET A 263 | NoneGOL A1341 (-3.7A)NoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.30A | 5m66C-2wabA:5.3 | 5m66C-2wabA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | THR A 315GLN A 299GLY A 306HIS A 310MET A 263 | GOL A1341 (-3.7A)NoneNoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.36A | 5m66C-2wabA:5.3 | 5m66C-2wabA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3azq | AMINOPEPTIDASE (Streptomycesmorookaense) |
PF00326(Peptidase_S9) | 5 | THR A 531ASP A 445LEU A 533GLY A 509PHE A 449 | None | 1.32A | 5m66C-3azqA:undetectable | 5m66C-3azqA:21.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 156THR A 219LYS A 248ASP A 252LEU A 407 | ADN A 500 (-2.9A)NAD A 550 ( 2.8A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-4.2A) | 1.21A | 5m66C-3ce6A:61.1 | 5m66C-3ce6A:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 69THR A 71GLN A 73ASP A 156THR A 219LYS A 248ASP A 252LEU A 410GLY A 415HIS A 416MET A 421PHE A 425 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.6A)ADN A 500 (-2.9A)NAD A 550 ( 2.8A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.17A | 5m66C-3ce6A:61.1 | 5m66C-3ce6A:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 69THR A 74ASP A 156THR A 219ASP A 252 | ADN A 500 (-4.0A)ADN A 500 (-4.5A)ADN A 500 (-2.9A)NAD A 550 ( 2.8A)ADN A 500 (-2.7A) | 1.30A | 5m66C-3ce6A:61.1 | 5m66C-3ce6A:58.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d8k | PROTEIN PHOSPHATASE2C (Toxoplasmagondii) |
PF00481(PP2C) | 5 | THR A 330ASP A 328GLY A 249HIS A 268PHE A 164 | None | 1.25A | 5m66C-3d8kA:undetectable | 5m66C-3d8kA:21.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 52THR A 54GLN A 56ASP A 130THR A 156LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-3.8A)ADN A 438 (-4.1A)NAD A 439 ( 3.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.51A | 5m66C-3g1uA:56.6 | 5m66C-3g1uA:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130THR A 156MET A 357 | ADN A 438 (-4.0A)ADN A 438 (-4.6A)ADN A 438 (-4.1A)NAD A 439 ( 3.0A)ADN A 438 (-3.7A) | 1.48A | 5m66C-3g1uA:56.6 | 5m66C-3g1uA:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.37A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64GLN A 66ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.41A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gvp | ADENOSYLHOMOCYSTEINASE 3 (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 234THR A 236GLN A 238ASP A 310LYS A 365 | None | 0.86A | 5m66C-3gvpA:42.4 | 5m66C-3gvpA:46.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 52THR A 54GLN A 56ASP A 130THR A 156LYS A 185ASP A 189LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)ADN A 439 (-3.6A)NoneNAD A 438 (-3.8A)NAD A 438 ( 3.9A)NAD A 438 ( 4.4A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.27A | 5m66C-3h9uA:57.1 | 5m66C-3h9uA:58.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130THR A 156ASP A 189 | ADN A 439 ( 4.7A)ADN A 439 (-4.7A)NoneNAD A 438 (-3.8A)NAD A 438 ( 4.4A) | 1.41A | 5m66C-3h9uA:57.1 | 5m66C-3h9uA:58.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3im9 | MALONYL COA-ACYLCARRIER PROTEINTRANSACYLASE (Staphylococcusaureus) |
PF00698(Acyl_transf_1) | 5 | THR A 59GLN A 11THR A 124GLY A 57PHE A 198 | ACT A 801 (-3.9A)ACT A 801 ( 3.8A)NoneNoneACT A 801 (-4.4A) | 1.32A | 5m66C-3im9A:undetectable | 5m66C-3im9A:22.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 132THR A 193LYS A 222ASP A 226LEU A 378HIS A 387 | ADN A 500 (-3.3A)NAD A 550 ( 3.0A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 (-3.4A) | 1.35A | 5m66C-3n58A:62.3 | 5m66C-3n58A:69.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 55THR A 57GLN A 59ASP A 132THR A 193LYS A 222ASP A 226LEU A 381GLY A 386HIS A 387MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A) K A 2 ( 3.3A)ADN A 500 (-3.3A)NAD A 550 ( 3.0A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.15A | 5m66C-3n58A:62.3 | 5m66C-3n58A:69.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 132THR A 193ASP A 226 | ADN A 500 (-4.0A)ADN A 500 (-4.6A)ADN A 500 (-3.3A)NAD A 550 ( 3.0A)ADN A 500 ( 2.6A) | 1.28A | 5m66C-3n58A:62.3 | 5m66C-3n58A:69.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nio | GUANIDINOBUTYRASE (Pseudomonasaeruginosa) |
PF00491(Arginase) | 5 | HIS A 154ASP A 245THR A 255GLY A 169HIS A 168 | MN A1602 (-3.3A) MN A1602 (-2.2A)NoneNoneNone | 1.31A | 5m66C-3nioA:undetectable | 5m66C-3nioA:21.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62ASP A 139LYS A 235ASP A 239LEU A 395 | ADE A 506 (-4.6A)NoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A) | 1.34A | 5m66C-3oneA:57.3 | 5m66C-3oneA:62.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64GLN A 66ASP A 139THR A 206LYS A 235ASP A 239LEU A 398GLY A 403HIS A 404MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)NoneNAD A 501 (-2.8A)NAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.17A | 5m66C-3oneA:57.3 | 5m66C-3oneA:62.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139THR A 206ASP A 239 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 (-2.8A)NAD A 501 ( 4.5A) | 1.30A | 5m66C-3oneA:57.3 | 5m66C-3oneA:62.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvf | FOMA PROTEIN (Streptomyceswedmorensis) |
PF00696(AA_kinase) | 5 | ASP A 150THR A 215ASP A 208GLY A 54HIS A 58 | MG A5000 (-4.0A)NoneADP A1260 ( 3.9A)FV1 A4001 (-3.2A)FV1 A4001 (-4.0A) | 1.30A | 5m66C-3qvfA:2.2 | 5m66C-3qvfA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvf | FOMA PROTEIN (Streptomyceswedmorensis) |
PF00696(AA_kinase) | 5 | ASP A 150THR A 215ASP A 208GLY A 57HIS A 58 | MG A5000 (-4.0A)NoneADP A1260 ( 3.9A)FV1 A4001 (-3.4A)FV1 A4001 (-4.0A) | 1.35A | 5m66C-3qvfA:2.2 | 5m66C-3qvfA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rre | PUTATIVEUNCHARACTERIZEDPROTEIN (Thermotogamaritima) |
PF01256(Carb_kinase)PF03853(YjeF_N) | 5 | THR A 171ASP A 55ASP A 5GLY A 173HIS A 198 | NoneGOL A 496 (-3.1A)GOL A 496 (-2.9A)NoneNone | 1.41A | 5m66C-3rreA:6.2 | 5m66C-3rreA:25.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sl1 | ARGINASE (Plasmodiumfalciparum) |
PF00491(Arginase) | 5 | HIS A 218ASP A 325THR A 335GLY A 234HIS A 233 | MN A 412 ( 3.3A) MN A 412 ( 2.0A)NoneFB6 A 414 (-3.6A)FB6 A 414 (-3.5A) | 1.28A | 5m66C-3sl1A:2.8 | 5m66C-3sl1A:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b43 | TRANSLATIONINITIATION FACTORIF-2 (Thermusthermophilus) |
PF00009(GTP_EFTU)PF04760(IF2_N) | 5 | HIS A 109THR A 107ASP A 126THR A 127ASP A 91 | None | 1.40A | 5m66C-4b43A:undetectable | 5m66C-4b43A:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxq | ARGINASE-1 (Homo sapiens) |
PF00491(Arginase) | 5 | HIS A 126ASP A 234THR A 244GLY A 142HIS A 141 | MN A 902 ( 3.4A) MN A 902 ( 2.0A)NoneX8A A 901 ( 3.7A)X8A A 901 (-3.4A) | 1.35A | 5m66C-4hxqA:2.2 | 5m66C-4hxqA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iu4 | ARGINASE (Leishmaniamexicana) |
PF00491(Arginase) | 5 | HIS A 139ASP A 245THR A 255GLY A 155HIS A 154 | MN A 402 ( 3.4A) MN A 402 ( 2.0A)NoneS2C A 405 ( 3.7A)S2C A 405 (-3.2A) | 1.33A | 5m66C-4iu4A:2.3 | 5m66C-4iu4A:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ixu | ARGINASE-2,MITOCHONDRIAL (Homo sapiens) |
PF00491(Arginase) | 5 | HIS A 145ASP A 253THR A 263GLY A 161HIS A 160 | MN A 402 ( 3.3A) MN A 402 ( 2.0A)None38I A 406 ( 3.7A)38I A 406 (-3.5A) | 1.29A | 5m66C-4ixuA:3.1 | 5m66C-4ixuA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j9u | TRK SYSTEM POTASSIUMUPTAKE PROTEIN TRKH (Vibrioparahaemolyticus) |
PF02386(TrkH) | 5 | THR A 325GLN A 313ASP A 305THR A 301GLY A 327 | None | 1.37A | 5m66C-4j9uA:undetectable | 5m66C-4j9uA:23.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60GLN A 62ASP A 135THR A 198LYS A 227ASP A 231LEU A 386GLY A 391HIS A 392MET A 397PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)NH4 A 502 ( 3.1A)ADN A 501 (-3.0A)NAD A 503 ( 2.9A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.18A | 5m66C-4lvcA:68.2 | 5m66C-4lvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 135THR A 198ASP A 231 | ADN A 501 (-4.0A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)NAD A 503 ( 2.9A)ADN A 501 (-3.1A) | 1.27A | 5m66C-4lvcA:68.2 | 5m66C-4lvcA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mca | GLYCEROLDEHYDROGENASE (Serratiaplymuthica) |
PF00465(Fe-ADH) | 5 | HIS A 254ASP A 171THR A 120LEU A 250GLY A 249 | ZN A1000 (-3.1A) ZN A1000 (-2.1A)NoneNoneNone | 1.31A | 5m66C-4mcaA:undetectable | 5m66C-4mcaA:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3r | ARGINASE (Schistosomamansoni) |
PF00491(Arginase) | 5 | HIS A 156ASP A 264THR A 274GLY A 172HIS A 171 | MN A 402 ( 3.3A) MN A 402 ( 2.1A)NoneXA2 A 407 ( 3.8A)XA2 A 407 (-3.2A) | 1.36A | 5m66C-4q3rA:2.7 | 5m66C-4q3rA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xa7 | NA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT C (Vibrio harveyi) |
PF04205(FMN_bind) | 5 | GLN A 192THR A 238LEU A 225GLY A 224PHE A 193 | None | 1.37A | 5m66C-4xa7A:undetectable | 5m66C-4xa7A:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ghs | SSDNA-SPECIFICEXONUCLEASE (Thermococcuskodakarensis) |
PF02272(DHHA1) | 5 | ASP A 279ASP A 171LEU A 179GLY A 176HIS A 175 | None | 1.18A | 5m66C-5ghsA:2.6 | 5m66C-5ghsA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5htv | PUTATIVE XYLULOSEKINASE (Arabidopsisthaliana) |
PF00370(FGGY_N)PF02782(FGGY_C) | 5 | THR A 234THR A 247ASP A 283LEU A 425GLY A 208 | None | 1.16A | 5m66C-5htvA:undetectable | 5m66C-5htvA:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ods | CLATHRIN HEAVY CHAIN1 (Mus musculus) |
no annotation | 5 | GLN A 265LYS A 36ASP A 35GLY A 314HIS A 309 | None | 1.44A | 5m66C-5odsA:undetectable | 5m66C-5odsA:12.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 53THR A 55ASP A 137THR A 212LYS A 241ASP A 245LEU A 404GLY A 409HIS A 410MET A 415PHE A 419 | SAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)NAD A 501 ( 4.1A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.34A | 5m66C-5utuA:54.7 | 5m66C-5utuA:51.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 53THR A 58ASP A 137THR A 212ASP A 245 | SAH A 502 (-4.0A)SAH A 502 (-4.2A)SAH A 502 (-3.4A)NAD A 501 ( 4.1A)SAH A 502 (-2.8A) | 1.45A | 5m66C-5utuA:54.7 | 5m66C-5utuA:51.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 59THR A 61ASP A 136THR A 198LYS A 227ASP A 231LEU A 389GLY A 394HIS A 395MET A 400PHE A 404 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)NAD A 501 ( 2.9A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.12A | 5m66C-5v96A:63.0 | 5m66C-5v96A:62.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 59THR A 64ASP A 136THR A 198ASP A 231 | ADN A 502 ( 3.9A)ADN A 502 (-4.4A)ADN A 502 (-2.9A)NAD A 501 ( 2.9A)ADN A 502 (-2.8A) | 1.23A | 5m66C-5v96A:63.0 | 5m66C-5v96A:62.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 131LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.96A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | HIS A 55THR A 57ASP A 131THR A 157LYS A 186ASP A 190MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.77A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 131THR A 157ASP A 190 | 9W4 A 502 (-3.7A)NoneNoneNoneNAD A 501 (-4.1A) | 1.46A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190GLY A 352HIS A 353MET A 358PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.95A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190LEU A 347GLY A 352HIS A 353MET A 358 | NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 0.91A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 157LYS A 186ASP A 190LEU A 347MET A 358 | NoneNoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)9W4 A 502 (-3.6A) | 1.18A | 5m66C-5w4bA:47.9 | 5m66C-5w4bA:57.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xn8 | GLYCEROLDEHYDROGENASE (unidentified) |
PF00465(Fe-ADH) | 5 | HIS A 254ASP A 171THR A 120LEU A 250GLY A 249 | ZN A 401 (-3.4A) ZN A 401 (-2.3A)NoneNoneNone | 1.21A | 5m66C-5xn8A:3.2 | 5m66C-5xn8A:22.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 136THR A 162LYS A 191ASP A 195LEU A 349 | ADN A 501 (-3.0A)NAD A 500 ( 2.9A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A) | 1.14A | 5m66C-6aphA:58.0 | 5m66C-6aphA:60.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60GLN A 62ASP A 136THR A 162LYS A 191ASP A 195LEU A 352GLY A 357HIS A 358MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.8A)ADN A 501 (-3.0A)NAD A 500 ( 2.9A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.15A | 5m66C-6aphA:58.0 | 5m66C-6aphA:60.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136THR A 162ASP A 195 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)NAD A 500 ( 2.9A)ADN A 501 (-2.7A) | 1.26A | 5m66C-6aphA:58.0 | 5m66C-6aphA:60.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6btm | ALTERNATIVE COMPLEXIII SUBUNIT B (Flavobacteriumjohnsoniae) |
no annotation | 5 | ASP B 580THR B 583LEU B 288GLY B 765PHE B 578 | None | 1.39A | 5m66C-6btmB:2.4 | 5m66C-6btmB:11.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 12 | HIS B 61THR B 63GLN B 65ASP B 139THR B 165LYS B 194ASP B 198LEU B 376GLY B 381HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A) ZN B 505 ( 2.5A)NAD B 501 ( 2.8A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.17A | 5m66C-6f3mB:53.9 | 5m66C-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 6 | HIS B 61THR B 66ASP B 139THR B 165ASP B 198MET B 387 | ADN B 502 ( 4.0A)ADN B 502 (-4.6A) ZN B 505 ( 2.5A)NAD B 501 ( 2.8A)ADN B 502 (-2.7A)ADN B 502 (-3.7A) | 1.36A | 5m66C-6f3mB:53.9 | 5m66C-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | HIS A 56THR A 58GLN A 60ASP A 134THR A 160LYS A 189ASP A 193LEU A 350GLY A 355HIS A 356MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A) NA A 503 ( 3.2A)ADN A 501 (-2.9A)NAD A 502 ( 2.8A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.17A | 5m66C-6gbnA:58.2 | 5m66C-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134THR A 160ASP A 193 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)NAD A 502 ( 2.8A)ADN A 501 (-2.7A) | 1.24A | 5m66C-6gbnA:58.2 | 5m66C-6gbnA:undetectable |